HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 81 filers reported holding HARPOON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $304 | -4.7% | 428 | 0.0% | 0.00% | – |
| Q1 2023 | $319 | -69.3% | 428 | -70.1% | 0.00% | – |
| Q4 2022 | $1,038 | -100.0% | 1,431 | -40.0% | 0.00% | – |
| Q3 2022 | $2,313,000 | -90.7% | 2,384 | -81.6% | 0.00% | – |
| Q2 2022 | $24,803,000 | +158.0% | 12,986 | +571.5% | 0.00% | – |
| Q1 2022 | $9,612,000 | -70.6% | 1,934 | -55.3% | 0.00% | – |
| Q4 2021 | $32,684,000 | +10.2% | 4,329 | +15.3% | 0.00% | – |
| Q3 2021 | $29,664,000 | +133.7% | 3,755 | +310.4% | 0.00% | – |
| Q2 2021 | $12,691,000 | -64.4% | 915 | -46.3% | 0.00% | – |
| Q1 2021 | $35,627,000 | +8.6% | 1,703 | -13.8% | 0.00% | – |
| Q4 2020 | $32,805,000 | -23.0% | 1,975 | -21.3% | 0.00% | – |
| Q3 2020 | $42,611,000 | +546.6% | 2,508 | +531.7% | 0.00% | – |
| Q2 2020 | $6,590,000 | -75.0% | 397 | -82.5% | 0.00% | – |
| Q1 2020 | $26,310,000 | +21.9% | 2,272 | +55.7% | 0.00% | – |
| Q4 2019 | $21,579,000 | +153.2% | 1,459 | +133.8% | 0.00% | – |
| Q3 2019 | $8,524,000 | +32.2% | 624 | +25.8% | 0.00% | – |
| Q2 2019 | $6,448,000 | – | 496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |